menu search

DBVT / DBV Technologies to Present New Data at ACAAI 2023

DBV Technologies to Present New Data at ACAAI 2023
Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12-month results from the ongoing Phase 3 open-label extension to the EPITOPE trial (EPOPEX) of Viaskin™ Peanut in peanut-allergic toddlers. DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that new data on the use of Viaskin™ Peanut (DBV712) 250 μg in peanut-allergic toddlers will be presented at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting, which is being held Thursday, November 9 – Monday, November 13, 2023, in Anaheim, CA. Read More
Posted: Nov 2 2023, 16:30
Author Name: GlobeNewsWire
Views: 091921

DBVT News  

DBV Technologies to Present New Data at ACAAI 2023

By GlobeNewsWire
November 2, 2023

DBV Technologies to Present New Data at ACAAI 2023

Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12 more_horizontal

DBV Technologies S.A. (DBVT) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 31, 2023

DBV Technologies S.A. (DBVT) Q3 2023 Earnings Call Transcript

DBV Technologies S.A. (NASDAQ:DBVT ) Q3 2023 Earnings Conference Call October 31, 2023 5:00 PM ET Company Participants Katie Matthews - Head of Invest more_horizontal

DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update

By GlobeNewsWire
October 27, 2023

DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update

Montrouge, France, October 27, 2023 DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update DBV Technologies (Euronext: DB more_horizontal

DBV Technologies to Participate in Upcoming Investor Conference

By GlobeNewsWire
September 5, 2023

DBV Technologies to Participate in Upcoming Investor Conference

Montrouge, France, September 5, 2023 D BV Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR0010 more_horizontal

DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update

By GlobeNewsWire
July 25, 2023

DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update

Montrouge, France, July 25, 2023 DBV Technologies to Report First Half 202 3 Financial Results and Provide a Corporate Update DBV Technologies (Eurone more_horizontal

DBV Technologies to Participate in Upcoming Investor Conference

By GlobeNewsWire
June 6, 2023

DBV Technologies to Participate in Upcoming Investor Conference

Montrouge, France, June 06, 2023 DB V Technologies to Participate in Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR00104173 more_horizontal

Why Shares of DBV Technologies Jumped Thursday

By The Motley Fool
May 11, 2023

Why Shares of DBV Technologies Jumped Thursday

The company's peanut allergy treatment patch could have a wide impact. DBV Technologies currently has no marketed products. more_horizontal

DBV Technologies S.A. (DBVT) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 3, 2023

DBV Technologies S.A. (DBVT) Q4 2022 Earnings Call Transcript

DBV Technologies S.A. (NASDAQ:DBVT ) Q4 2022 Results Conference Call March 2, 2023 5:00 PM ET Company Participants Anne Pollak - Head IR Daniel Tassé more_horizontal


Search within

Pages Search Results: